Literature DB >> 9396453

Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.

P Bruins1, H te Velthuis, A P Yazdanbakhsh, P G Jansen, F W van Hardevelt, E M de Beaumont, C R Wildevuur, L Eijsman, A Trouwborst, C E Hack.   

Abstract

BACKGROUND: Complement activation during cardiopulmonary bypass (CPB) surgery is considered to result from interaction of blood with the extracorporeal circuit. We investigated whether additional mechanisms may contribute to complement activation during and after CPB and, in particular, focused on a possible role of the acute-phase protein C-reactive protein (CRP). METHODS AND
RESULTS: In 19 patients enrolled for myocardial revascularization, perioperative and postoperative levels of complement activation products, interleukin-6 (IL-6), CRP, and complement-CRP complexes, reflecting CRP-mediated complement activation in vivo, were measured and related to clinical symptoms. A biphasic activation of complement was observed. The ratio between the areas under the curve of perioperative and postoperative C3b/c and C4b/c were 3:2 and 1:46, respectively. IL-6 levels reached a maximum at 6 hours post-surgery. CRP levels peaked on the second postoperative day. Each complement-CRP complex had peak levels on the second or third postoperative day. By multivariate analysis, maximum levels of CRP on the second postoperative day were mainly explained by C4b/c levels after protamine administration, leukocyte count on the second postoperative day, and preoperative levels of CRP. Peak levels of C4b/c after protamine administration (P=.0073) and on the second postoperative day correlated with the occurrence of arrhythmia on the same day (P=.0065).
CONCLUSIONS: Cardiac surgery with CPB causes a biphasic complement activation. The first phase occurs during CPB and results from the interaction of blood with the extracorporeal circuit. The second phase, which occurs during the first 5 days after surgery, involves CRP, is related to baseline CRP levels, and is associated with clinical symptoms such as arrhythmia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396453     DOI: 10.1161/01.cir.96.10.3542

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  153 in total

1.  Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

Authors:  Diederik F van Wijk; Sander I van Leuven; Manjinder S Sandhu; Michael W Tanck; Barbara A Hutten; Nicholas J Wareham; John J P Kastelein; Erik S G Stroes; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

2.  Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation.

Authors:  Mónica Acevedo; Ramón Corbalán; Sandra Braun; Jaime Pereira; Ilse González; Carlos Navarrete
Journal:  J Thromb Thrombolysis       Date:  2012-02-03       Impact factor: 2.300

3.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

4.  Left atrial epicardial adiposity and atrial fibrillation.

Authors:  Omar Batal; Paul Schoenhagen; Mingyuan Shao; Ala Eddin Ayyad; David R Van Wagoner; Sandra S Halliburton; Patrick J Tchou; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-05-26

Review 5.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

6.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

7.  Helicobacter pylori and atrial fibrillation: a possible pathogenic link.

Authors:  A S Montenero; N Mollichelli; F Zumbo; A Antonelli; A Dolci; M Barberis; C Sirolla; T Staine; L Fiocca; N Bruno; S O'Connor
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 8.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

9.  Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.

Authors:  Wanwarat Ananthapanyasut; Sirikarn Napan; Earl H Rudolph; Tasma Harindhanavudhi; Husam Ayash; Kelly E Guglielmi; Edgar V Lerma
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 8.237

10.  High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery.

Authors:  Zhong-Kai Wu; Jari Laurikka; Saila Vikman; Riina Nieminen; Eeva Moilanen; Matti R Tarkka
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.